Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Competitive magneto enzyme-linked miRNA assay for quantification of microRNAs in exosomes

  • Bernuz, Mireia|||0000-0002-2052-6902
  • Martí, Mercè|||0000-0002-1846-0043
  • Pividori, María Isabel|||0000-0002-5266-7873
MicroRNAs (miRNAs) are non-coding, short RNA sequences involved in gene regulation. Although intracellular molecules, miRNAs are also found in biological fluids, where they serve as promising diagnostic and prognostic biomarkers. In liquid biopsies, miRNAs are protected from RNase activity through association with proteins or as part of the exosomal cargo. Current methods for miRNA detection are technically demanding and resource intensive. Here, we present a competitive magneto enzyme-linked miRNA (ELmiRNA) assay for the direct quantification of miRNAs in exosomes. The assay is based on a DNA scaffold containing two miRNA templates, each hybridized to a complementary double-tagged probe and anchored via a poly(A) tail to oligo(dT)-magnetic particles. Upon incubation with miRNA-containing samples, displacement of the tagged probes occurs, enabling indirect quantification through enzymatic labeling. As proof of concept, miRNA-21 and miRNA-27a, both upregulated in breast cancer, were quantified in MCF-7 and MDA-MB-231 cells and their derived exosomes. The assay achieved limits of detection of 1.5 nM (9.6 pg μL) and 2.7 nM (16.2 pg μL) for miRNA-21 and miRNA-27a, respectively, and yielded 10-30 copies per exosome, in agreement with RT-qPCR validation. The ELmiRNA assay combines sensitivity and selectivity with high-throughput analysis using a routine laboratory filter-based microplate reader. This approach represents a simplified, amplification-free alternative to RT-qPCR for miRNA quantification in exosomes, suitable for routine implementation in standard clinical and research laboratories.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Rapid diagnostic test for assessment of cellular immune response in a viral infection as a model

  • Bernuz, Mireia|||0000-0002-2052-6902
  • Porras, Juan Carlos
  • Egri, Natalia|||0000-0001-7698-0672
  • González-Navarro, Europa Azucena|||0000-0003-3310-5557
  • Juan, Manel|||0000-0002-3064-1648
  • Pividori, María Isabel|||0000-0002-5266-7873
  • Martí, Mercè|||0000-0002-1846-0043
The global SARS-CoV-2 pandemic has highlighted the critical importance of evaluating adaptive immunological status in both infected individuals and those who have been vaccinated. While the humoral immune response has been extensively studied, the cellular immune component has not progressed as rapidly due to challenges in developing rapid diagnostic tests for activated T cells. This study introduces a rapid, user-friendly assay aimed at addressing this need by using the early expression of interferon-gamma (IFN-γ) transcripts for rapid and direct evaluation. Using a novel design, this assay measures IFN-γ mRNA rather than its protein levels, thereby significantly shortening the time to result compared to traditional methods. The process involves incubating whole blood with a mixture of Spike and Nucleocapsid peptides, followed by immunomagnetic separation of CD3+ T cells and subsequent double-tagging RT-PCR. A lateral flow assay (LFA) is then used for detection, allowing IFN-γ mRNA levels to be assessed rapidly. Non-stimulated samples are used as controls to establish baseline IFN-γ expression. The intensity of the LFA signals from the stimulated samples is then compared to these baseline values using a smartphone interface. Furthermore, the study includes a time course analysis to monitor the T cell response dynamics over time in infected individuals. This LFA-IFN-γ represents a significant progress in the field of rapid diagnostics, offering a one-day protocol that simplifies testing procedures and is especially suitable for low-resource settings.